Non-Alcoholic Fatty Live Disease
Sex hormone-binding globulin level may predict liver fibrosis for men with NAFLD
SAN DIEGO — Higher sex hormone-binding globulin levels may predict liver fibrosis for men with nonalcoholic fatty liver disease, according to a presenter at the AACE Annual Scientific and Clinical Conference.
Fibrotic NASH score may help health care providers predict at-risk patients
AHA: Addressing ‘undiagnosed’ NAFLD could mitigate CVD risk
Nonalcoholic fatty liver disease remains widely undiagnosed, yet early identification and treatment could mitigate long-term risk for CVD, according to a new American Heart Association scientific statement.
Weight loss via endoscopic bariatric therapies improves ‘all major NAFLD outcomes’
Weight loss induced by FDA-approved endoscopic bariatric and metabolic therapies improved several features of nonalcoholic fatty liver disease, with significant improvement in liver fibrosis, according to research.
Long, irregular menstrual cycles may increase NAFLD risk for premenopausal women
Premenopausal women with long or irregular menstrual cycles have a higher risk for prevalent and incident nonalcoholic fatty liver disease compared with women with normal cycles, according to study findings.
Noninvasive testing for NAFLD crucial for people with diabetes
Providers should closely monitor people with diabetes and other high-risk adults for nonalcoholic fatty liver disease and consider multiple noninvasive tests to detect the presence of advanced fibrosis, according to a speaker.
Should the name ‘NAFLD’ change to reflect an emphasis on dysregulated metabolism?
In the past, we did not really know what caused nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. The major cause of liver problems at that point was alcohol, yet clinicians were observing cases of steatohepatitis or cirrhosis among people who were not excessive alcohol drinkers. That is how a name with “nonalcoholic” emerged. Even 30 years ago, obesity was not as prevalent as it is today.
Intersection between heart and liver a rapidly evolving field
About 25% of U.S. adults have nonalcoholic fatty liver disease, which is the most common chronic liver condition in the U.S., according to the American Liver Foundation.
‘All of us need to be vigilant’: Steps to combat growing NAFLD, NASH epidemic
The incidence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis continues to rise with obesity and type 2 diabetes, and all clinicians must screen patients at high cardiometabolic risk, according to a speaker.
Those with fatty liver at 5 times greater risk for death from COVID
Patients with metabolic-associated fatty liver disease or higher transaminases who were then diagnosed with COVID-19 were more likely to die, according to a presenter at the International Liver Congress